Your browser doesn't support javascript.
loading
Genetic analysis in patients with newly diagnosed glioblastomas treated with interferon-beta plus temozolomide in comparison with temozolomide alone.
Natsume, Atsushi; Aoki, Kosuke; Ohka, Fumiharu; Maeda, Sachi; Hirano, Masaki; Adilijiang, Alimu; Motomura, Kazuya; Sumi, Minako; Nishikawa, Ryo; Narita, Yoshitaka; Muragaki, Yoshihiro; Maruyama, Takashi; Ito, Tamio; Beppu, Takaaki; Nakamura, Hideo; Kayama, Takamasa; Sato, Shinya; Nagane, Motoo; Mishima, Kazuhiko; Nakasu, Yoko; Kurisu, Kaoru; Yamasaki, Fumiyuki; Sugiyama, Kazuhiko; Onishi, Takanori; Iwadate, Yasuo; Terasaki, Mizuhiko; Kobayashi, Hiroyuki; Matsumura, Akira; Ishikawa, Eiichi; Sasaki, Hikaru; Mukasa, Akitake; Matsuo, Takayuki; Hirano, Hirofumi; Kumabe, Toshihiro; Shinoura, Nobusada; Hashimoto, Naoya; Aoki, Tomokazu; Asai, Akio; Abe, Tatsuya; Yoshino, Atsuo; Arakawa, Yoshiki; Asano, Kenichiro; Yoshimoto, Koji; Shibui, Soichiro; Okuno, Yusuke; Wakabayashi, Toshihiko.
Afiliación
  • Natsume A; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan. anatsume@med.nagoya-u.ac.jp.
  • Aoki K; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Ohka F; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Maeda S; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Hirano M; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Adilijiang A; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Motomura K; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Sumi M; Radiation Oncology Department, Cancer Institute Hospital, Tokyo, Japan.
  • Nishikawa R; Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, Saitama, Japan.
  • Narita Y; Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Muragaki Y; Department of Neurosurgery, Tokyo Women's Medical University, Tokyo, Japan.
  • Maruyama T; Department of Neurosurgery, Tokyo Women's Medical University, Tokyo, Japan.
  • Ito T; Department of Neurosurgery, Nakamura Memorial Hospital, Sapporo, Japan.
  • Beppu T; Department of Neurosurgery, Iwate Medical University, Iwate, Japan.
  • Nakamura H; Department of Neurosurgery, Kumamoto University Graduate School of Medicine, Kumamoto, Japan.
  • Kayama T; Department of Neurosurgery, Yamagata University Graduate School of Medicine, Yamagata, Japan.
  • Sato S; Department of Neurosurgery, Yamagata University Graduate School of Medicine, Yamagata, Japan.
  • Nagane M; Department of Neurosurgery, Faculty of Medicine, Kyorin University, Tokyo, Japan.
  • Mishima K; Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, Saitama, Japan.
  • Nakasu Y; Department of Neurosurgery, Shizuoka Cancer Center, Shizuoka, Japan.
  • Kurisu K; Department of Neurosurgery, Hiroshima University Hospital, Hiroshima, Japan.
  • Yamasaki F; Department of Neurosurgery, Hiroshima University Hospital, Hiroshima, Japan.
  • Sugiyama K; Department of Clinical Oncology & Neuro-Oncology Program, Hiroshima University Hospital, Hiroshima, Japan.
  • Onishi T; Department of Neurosurgery, Ehime University Graduate School of Medicine, Ehime, Japan.
  • Iwadate Y; Department of Neurological Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Terasaki M; Department of Neurosurgery, Kurume University Graduate School of Medicine, Kurume, Japan.
  • Kobayashi H; Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
  • Matsumura A; Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Ishikawa E; Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Sasaki H; Department of Neurosurgery, Keio University School of Medicine, Tokyo, Japan.
  • Mukasa A; Department of Neurosurgery, The University of Tokyo Hospital, Tokyo, Japan.
  • Matsuo T; Department of Neurosurgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Hirano H; Department of Neurosurgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
  • Kumabe T; Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Shinoura N; Department of Neurosurgery, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan.
  • Hashimoto N; Department of Neurosurgery, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Aoki T; Department of Neurosurgery, Kitano Hospital, Osaka, Japan.
  • Asai A; Department of Neurosurgery, Kansai Medical University, Osaka, Japan.
  • Abe T; Department of Neurosurgery, Faculty of Medicine, Oita University, Oita, Japan.
  • Yoshino A; Department of Neurological Surgery, Nihon University Graduate School of Medicine, Tokyo, Japan.
  • Arakawa Y; Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Asano K; Department of Neurosurgery, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Yoshimoto K; Department of Neurosurgery, Graduate School of Medical Sciences, Kyusyu University, Fukuoka, Japan.
  • Shibui S; Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Okuno Y; Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan.
  • Wakabayashi T; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
J Neurooncol ; 148(1): 17-27, 2020 May.
Article en En | MEDLINE | ID: mdl-32367437
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Interferón beta / Glioblastoma / Temozolomida / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Interferón beta / Glioblastoma / Temozolomida / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article